Global Diagnostic Radiopharmaceuticals Industry Growth and Trends Forecast to 2031

Summary

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

According to APO Research, The global Diagnostic Radiopharmaceuticals market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Diagnostic Radiopharmaceuticals is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Diagnostic Radiopharmaceuticals is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Diagnostic Radiopharmaceuticals is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Diagnostic Radiopharmaceuticals include Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Advanced Accelerator Applications, SIEMENS, China Isotope & Radiation and Dongcheng Pharmaceutical Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals.

The Diagnostic Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Diagnostic Radiopharmaceuticals Segment by Company

Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly

Diagnostic Radiopharmaceuticals Segment by Type

Technetium 99
Fluorine 18
Other

Diagnostic Radiopharmaceuticals Segment by Application

Oncology
Cardiology
Other

Diagnostic Radiopharmaceuticals Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Radiopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Diagnostic Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts (2020-2031)
1.3 Diagnostic Radiopharmaceuticals Market by Type
1.3.1 Technetium 99
1.3.2 Fluorine 18
1.3.3 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Size by Type
1.4.1 Global Diagnostic Radiopharmaceuticals Market Size Overview by Type (2020-2031)
1.4.2 Global Diagnostic Radiopharmaceuticals Historic Market Size Review by Type (2020-2025)
1.4.3 Global Diagnostic Radiopharmaceuticals Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
1.5.2 Europe Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
1.5.4 South America Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics

2.1 Diagnostic Radiopharmaceuticals Industry Trends
2.2 Diagnostic Radiopharmaceuticals Industry Drivers
2.3 Diagnostic Radiopharmaceuticals Industry Opportunities and Challenges
2.4 Diagnostic Radiopharmaceuticals Industry Restraints
3 Market Competitive Landscape by Company

3.1 Global Top Players by Diagnostic Radiopharmaceuticals Revenue (2020-2025)
3.2 Global Top Players by Diagnostic Radiopharmaceuticals Sales (2020-2025)
3.3 Global Top Players by Diagnostic Radiopharmaceuticals Price (2020-2025)
3.4 Global Diagnostic Radiopharmaceuticals Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Diagnostic Radiopharmaceuticals Major Company Production Sites & Headquarters
3.6 Global Diagnostic Radiopharmaceuticals Company, Product Type & Application
3.7 Global Diagnostic Radiopharmaceuticals Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Diagnostic Radiopharmaceuticals Market CR5 and HHI
3.8.2 Global Top 5 and 10 Diagnostic Radiopharmaceuticals Players Market Share by Revenue in 2024
3.8.3 2023 Diagnostic Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Diagnostic Radiopharmaceuticals Regional Status and Outlook

4.1 Global Diagnostic Radiopharmaceuticals Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Diagnostic Radiopharmaceuticals Historic Market Size by Region
4.2.1 Global Diagnostic Radiopharmaceuticals Sales in Volume by Region (2020-2025)
4.2.2 Global Diagnostic Radiopharmaceuticals Sales in Value by Region (2020-2025)
4.2.3 Global Diagnostic Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Diagnostic Radiopharmaceuticals Forecasted Market Size by Region
4.3.1 Global Diagnostic Radiopharmaceuticals Sales in Volume by Region (2026-2031)
4.3.2 Global Diagnostic Radiopharmaceuticals Sales in Value by Region (2026-2031)
4.3.3 Global Diagnostic Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Diagnostic Radiopharmaceuticals by Application

5.1 Diagnostic Radiopharmaceuticals Market by Application
5.1.1 Oncology
5.1.2 Cardiology
5.1.3 Other
5.2 Global Diagnostic Radiopharmaceuticals Market Size by Application
5.2.1 Global Diagnostic Radiopharmaceuticals Market Size Overview by Application (2020-2031)
5.2.2 Global Diagnostic Radiopharmaceuticals Historic Market Size Review by Application (2020-2025)
5.2.3 Global Diagnostic Radiopharmaceuticals Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
5.3.2 Europe Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
5.3.4 South America Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
6 Company Profiles

6.1 Cardinal Health
6.1.1 Cardinal Health Comapny Information
6.1.2 Cardinal Health Business Overview
6.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
6.1.5 Cardinal Health Recent Developments
6.2 GE Healthcare
6.2.1 GE Healthcare Comapny Information
6.2.2 GE Healthcare Business Overview
6.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
6.2.5 GE Healthcare Recent Developments
6.3 Curium Pharma
6.3.1 Curium Pharma Comapny Information
6.3.2 Curium Pharma Business Overview
6.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.3.5 Curium Pharma Recent Developments
6.4 Jubilant Pharma
6.4.1 Jubilant Pharma Comapny Information
6.4.2 Jubilant Pharma Business Overview
6.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.4.5 Jubilant Pharma Recent Developments
6.5 Bracco Imaging
6.5.1 Bracco Imaging Comapny Information
6.5.2 Bracco Imaging Business Overview
6.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
6.5.5 Bracco Imaging Recent Developments
6.6 Advanced Accelerator Applications
6.6.1 Advanced Accelerator Applications Comapny Information
6.6.2 Advanced Accelerator Applications Business Overview
6.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
6.6.5 Advanced Accelerator Applications Recent Developments
6.7 SIEMENS
6.7.1 SIEMENS Comapny Information
6.7.2 SIEMENS Business Overview
6.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.7.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
6.7.5 SIEMENS Recent Developments
6.8 China Isotope & Radiation
6.8.1 China Isotope & Radiation Comapny Information
6.8.2 China Isotope & Radiation Business Overview
6.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
6.8.5 China Isotope & Radiation Recent Developments
6.9 Dongcheng Pharmaceutical Group
6.9.1 Dongcheng Pharmaceutical Group Comapny Information
6.9.2 Dongcheng Pharmaceutical Group Business Overview
6.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
6.9.5 Dongcheng Pharmaceutical Group Recent Developments
6.10 Lantheus
6.10.1 Lantheus Comapny Information
6.10.2 Lantheus Business Overview
6.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
6.10.5 Lantheus Recent Developments
6.11 Eli Lilly
6.11.1 Eli Lilly Comapny Information
6.11.2 Eli Lilly Business Overview
6.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
6.11.5 Eli Lilly Recent Developments
7 North America by Country

7.1 North America Diagnostic Radiopharmaceuticals Sales by Country
7.1.1 North America Diagnostic Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
7.1.3 North America Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2031)
7.2 North America Diagnostic Radiopharmaceuticals Market Size by Country
7.2.1 North America Diagnostic Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025)
7.2.3 North America Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2031)
8 Europe by Country

8.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
8.1.1 Europe Diagnostic Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
8.1.3 Europe Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2031)
8.2 Europe Diagnostic Radiopharmaceuticals Market Size by Country
8.2.1 Europe Diagnostic Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025)
8.2.3 Europe Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country

9.1 Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Country
9.1.1 Asia-Pacific Diagnostic Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
9.1.3 Asia-Pacific Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Diagnostic Radiopharmaceuticals Market Size by Country
9.2.1 Asia-Pacific Diagnostic Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2031)
10 South America by Country

10.1 South America Diagnostic Radiopharmaceuticals Sales by Country
10.1.1 South America Diagnostic Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
10.1.3 South America Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2031)
10.2 South America Diagnostic Radiopharmaceuticals Market Size by Country
10.2.1 South America Diagnostic Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025)
10.2.3 South America Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country

11.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country
11.1.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2020-2025)
11.1.3 Middle East and Africa Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Country
11.2.1 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis

12.1 Diagnostic Radiopharmaceuticals Value Chain Analysis
12.1.1 Diagnostic Radiopharmaceuticals Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Diagnostic Radiopharmaceuticals Production Mode & Process
12.2 Diagnostic Radiopharmaceuticals Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Diagnostic Radiopharmaceuticals Distributors
12.2.3 Diagnostic Radiopharmaceuticals Customers
13 Concluding Insights
14 Appendix

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings